---
title: "INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and ... — FDA record D-0298-2026 | Is It on Recall"
description: "Failed Disintegration Specifications: above the time expected."
url: https://isitonrecall.com/recall/fda-drug-d-0298-2026-inon-ace-antacid-tablets-magnesium-aluminosilicate-magnesium-hydroxide-and-simethicone-75-count-bott/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactu... — FDA record D-0298-2026

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Dec 19, 2025. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
- **Reason**: Failed Disintegration Specifications: above the time expected.
- **Classification**: Class II
- **Recalling firm**: Sato Pharmaceutical Co., Ltd
- **Quantity**: 3,640 bottles
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0298-2026

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0298-2026%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot#: PWXT, Exp 1/31/2027 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

CA and HI

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [California](https://isitonrecall.com/state/california/)
- [Hawaii](https://isitonrecall.com/state/hawaii/)

## Dates in the source

- **Report date**: Feb 4, 2026
- **Recall initiation date**: Dec 19, 2025
- **Center classification date**: Jan 27, 2026

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0298-2026%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Sato Pharmaceutical Co., Ltd records](https://isitonrecall.com/brand/sato-pharmaceutical-co-ltd/)